The DOI matches its Crossref record; 210 of the 210 references it cites were found in a registry or an index.
Ageing as a risk factor for neurodegenerative disease
Abstract
Ageing is the primary risk factor for most neurodegenerative diseases, including Alzheimer disease (AD) and Parkinson disease (PD). One in ten individuals aged ≥65 years has AD and its prevalence continues to increase with increasing age. Few or no effective treatments are available for ageing-related neurodegenerative diseases, which tend to progress in an irreversible manner and are associated with large socioeconomic and personal costs. This Review discusses the pathogenesis of AD, PD and other neurodegenerative diseases, and describes their associations with the nine biological hallmarks of ageing: genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, mitochondrial dysfunction, cellular senescence, deregulated nutrient sensing, stem cell exhaustion and altered intercellular communication. The central biological mechanisms of ageing and their potential as targets of novel therapies for neurodegenerative diseases are also discussed, with potential therapies including NAD+ precursors, mitophagy inducers and inhibitors of cellular senescence.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The use of primary human monocytes also has several advantages: (i) their human origin enables the study of human-specific disease phenotypes and molecular mechanisms, (ii) monocytes derived from patients with AD may contain cell-intrinsic properties specific to that patient, and (iii) monocytes derived from patients with AD and age-matched controls may exhibit age-relevant phenotypes, given that”
From Understanding monocyte-driven neuroinflammation in Alzheimer’s disease using human cortical organoid microphysiological systems (2025) · cites this paper as [75]
In the citing paper
“Aging, which remains the largest risk factor for LOAD, is associated with low-grade systemic inflammation (termed “inflammaging”) [20, 21].”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [21]
In the citing paper
“Age‐related alterations in the brain microenvironment gradually led to increased BBB permeability and leakiness, neuronal degeneration, production of reactive oxygen species (ROS) and inflammation. 54 , 55 , 56”
From Therapeutic Properties and Pharmacological Activities of Asiaticoside and Madecassoside: A Review (2023) · cites this paper as [54]
In the citing paper
“Aging is known to be the primary driver of many neurodegenerative diseases, including Alzheimer’s disease (AD) [53].”
From Senescence-related impairment of autophagy induces toxic intraneuronal amyloid-β accumulation in a mouse model of amyloid pathology (2023) · cites this paper as [53]
In the citing paper
“This concurrence could explain the strong link between increased age and ND [83].”
From Untangling senescent and damage‐associated microglia in the aging and diseased brain (2023) · cites this paper as [83]
In the citing paper
“Aging is the predominant risk factor for cognitive dysfunction (Kalache and Gatti, 2003; Partridge et al., 2018) and several neurodegenerative disorders, including Alzheimer's disease (AD) and Parkinson's disease (PD) (Hou et al., 2019; López-Otín et al., 2013; Niccoli et al., 2017).”
From Atlas of the aging mouse brain reveals white matter as vulnerable foci (2023) · cites this paper as Hou et al., 2019
Citations
Cites
2 retracted
Items 201–210 of 210
Drosophila melanogaster: Deciphering Alzheimer's Disease.
Tan, F. H., & Azzam, G. (2017) · Malaysian Journal of Medical Sciences · doi:10.21315/mjms2017.24.2.2 · Cited by 49
Vivar, C. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150610141524 · Cited by 46
Chen, J., Chen, Y., Vail, G., Chow, H., Zhang, Y., Louie, L., Li, J., Hart, R. P., Plummer, M. R., & Herrup, K. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0127-y · Cited by 37
The role of DNA base excision repair in brain homeostasis and disease
Akbari, M., Morevati, M., Croteau, D. L., & Bohr, V. A. (2015) · DNA repair · doi:10.1016/j.dnarep.2015.04.029 · Cited by 34
Self-citationTelomere shortening leads to earlier age of onset in ALS mice
Linkus, B., Wiesner, D., Meßner, M., Karabatsiakis, A., Scheffold, A., Rudolph, K. L., Thal, D. R., Weishaupt, J. H., Ludolph, A. C., & Danzer, K. M. (2016) · Aging · doi:10.18632/aging.100904 · Cited by 32
DNA plasticity and damage in amyotrophic lateral sclerosis
Kretz, A., Penndorf, D., & Witte, O. W. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.226377 · Cited by 31
Takamatsu, Y., Ho, G. J., Koike, W., Sugama, S., Takenouchi, T., Waragai, M., Wei, J., Sekiyama, K., & Hashimoto, M. (2017) · npj Parkinson s Disease · doi:10.1038/s41531-016-0001-1 · Cited by 26
Rejuvenation by Therapeutic Elimination of Senescent Cells
Krimpenfort, P., & Berns, A. J. M. (2017) · Cell · doi:10.1016/j.cell.2017.03.014 · Cited by 23
Base excision DNA repair and cancer
Tell, G., & Demple, B. (2014) · Oncotarget · doi:10.18632/oncotarget.2705 · Cited by 22
Ibuprofen prevents progression of ataxia telangiectasia symptoms in ATM-deficient mice
Hui, C. W., Song, X., Ma, F., Shen, X., & Herrup, K. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1338-7 · Cited by 22
Flagged first, then by citations
Cited by
Sorted by citations
Comprehensive Review on Alzheimer’s Disease: Causes and Treatment
Breijyeh, Z., & Karaman, R. (2020) · Molecules · doi:10.3390/molecules25245789 · Cited by 2,789
Aging and aging-related diseases: from molecular mechanisms to interventions and treatments
Guo, J., Huang, X., Dou, L., Yan, M., Shen, T., Tang, W., & Li, J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01251-0 · Cited by 1,976
Synergy between amyloid-β and tau in Alzheimer’s disease
Busche, M. A., & Hyman, B. T. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-0687-6 · Cited by 1,242
Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
Loh, J. S., Mak, W. Q., Tan, L. K. S., Ng, C. X., Chan, H. H., Yeow, S. H., Foo, J. B., Ong, Y. S., How, C. W., & Khaw, K. Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01743-1 · Cited by 1,193
Su, D., Cui, Y., He, C., Yin, P., Bai, R., Zhu, J., Lam, J. S. T., Zhang, J., Yan, R., Zheng, X., et al. (2025) · BMJ · doi:10.1136/bmj-2024-080952 · Cited by 751
Metadata
- Authors
- Hou, Y., Dan, X., Babbar, M., Wei, Y., Hasselbalch, S. G., Croteau, D. L., & Bohr, V. A.
- Affiliations
- National Institute on Aging (US)
- University of Copenhagen (DK)
- Corresponding author
- Bohr, Vilhelm A.
- ORCID
- Venue
- Nature Reviews Neurology
- Published
- 2019-09-09
- Volume
- 15
- Issue
- 10
- Pages
- 565-581
- ISSN
- 1759-4758 (ISSN-L)
- 1759-4766
- OpenAlex
- W2972368830
- Semantic Scholar
- 4f2aec225c7ce5314a73bd30acc5348f6086766b
- Cited by
- 3,310
- References
- 209
- Citations by year
- 2026: 441 · 2025: 639 · 2024: 675 · 2023: 534 · 2022: 474 · 2021: 359 · 2020: 178 · 2019: 8
- FWCI
- 22.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature Reviews Neurology (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Funders
- National Institute on Aging
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- aging, neurodegenerative diseases, Alzheimer's disease, Parkinson's disease, genomic instability, telomere shortening, epigenetic modifications, proteostasis, mitochondrial dysfunction, cellular senescence, nutrient sensing, stem cell exhaustion, intercellular communication, NAD+ precursors, mitophagy, senolytics, therapeutic target
- MeSH terms
- Aging, Brain, DNA Damage, Humans, Risk Factors, Neurodegenerative Diseases, Epigenesis, Genetic, Mitophagy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
